Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On January 3, 2020, Gregory Kitchener, the chief financial officer of Zosano
Pharma Corporation (the "Company"), notified the Company of his intent to resign
effective February 1, 2020. Mr. Kitchener informed the Company that he plans to
join a private software company in the technology industry.
(c) On January 7, 2020, the Board of Directors of the Company (the "Board")
appointed Christine Matthews as interim chief financial officer, effective
February 1, 2020. In her capacity as interim chief financial officer,
Ms. Matthews will serve as interim principal financial officer. In addition, the
Board appointed Ms. Matthews as the principal accounting officer of the Company.
The Company is searching for a permanent chief financial officer and principal
financial officer.
Ms. Matthews, age 51, has served as the Company's Vice President, Corporate
Controller, since January 2019. From August 2015 to January 2019, Ms. Matthews
served as an accounting and financial consultant with Resources Global
Professionals ("RGP"). Prior to joining RGP, from September 2013 to June 2015,
Ms. Matthews served as Senior Director of Finance at Cepheid, Inc., a
biotechnology company. Ms. Matthews received a B.S. in Business Administration
with an Emphasis in Accounting from the University of Colorado at Boulder.
There is no arrangement or understanding between Ms. Matthews and any other
person pursuant to which Ms. Matthews was appointed as interim chief financial
officer of the Company. There are no family relationships between Ms. Matthews
and any of the Company's directors or executive officers. There are no related
person transactions in which Ms. Matthews had or will have a direct or indirect
material interest required to be disclosed under Item 404(a) of Regulation S-K.
The Board has not approved any additional compensation for Ms. Matthews in
connection with her service as interim chief financial officer of the Company.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ZOSANO PHARMA CORPORATION 
